FGD3 mRNA expression did not correlate with TILs in the BIG 1-98 DASL and TCGA breast cancer cohorts, suggesting that the prognostic value of FGD3 is not indicating immune cells in patients’ tumors. This evidence concerns the gene FGD3 and breast cancer.